• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

bispecific antibodies

Disco ball dancefloor
Biotech

AbbVie busts a move with Disco in $2.5B bispecific dance

The deal, which comes with $50 million upfront, grants AbbVie use of Disco’s mapping platform for finding cancer targets on a cell’s surface.
Michael Gibney Nov 19, 2026 4:30am
FDA
Favicon Fierce Pharma

FDA slams China-heavy data in Summit’s ivonescimab CRL

Nov 17, 2026 4:48pm
FDA stop sign
Favicon Fierce Pharma

FDA rejects Summit’s PD-1xVEGF ivonescimab in NSCLC

Nov 15, 2026 7:50am
BioNTech
Favicon Fierce Pharma

BioNTech pays $205M for FDA voucher to speed up cancer pipeline

Nov 11, 2026 8:20am
Pipette dripping water droplet with money symbol on it into test tube

T-Therapeutics raises $133M series B with Big Pharma backers

Nov 5, 2026 4:00am
Merck  Co
Favicon Fierce Pharma

For Merck, 2027 is ‘another year of investment’

Oct 29, 2026 11:23am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings